200
Participants
Start Date
June 30, 1999
Primary Completion Date
June 30, 2002
Study Completion Date
June 30, 2002
motexafin gadolinium
biopsy
breast imaging study
comparison of screening methods
magnetic resonance imaging
study of high risk factors
Lombardi Cancer Center, Washington D.C.
Cancer Center at the University of Virginia, Charlottesville
University of Colorado Cancer Center, Denver
Porter Adventist Hospital, Denver
UCSF Cancer Center and Cancer Research Institute, San Francisco
Hartford Hospital, Hartford
Roswell Park Cancer Institute, Buffalo
Lineberger Comprehensive Cancer Center, UNC, Chapel Hill
University of Pennsylvania Cancer Center, Philadelphia
Simmons Cancer Center - Dallas, Dallas
University of Washington Medical Center, Seattle
University of Toronto, Toronto
National Cancer Institute (NCI)
NIH
Abramson Cancer Center at Penn Medicine
OTHER